Recent blog posts
Biological Glossary | What is Linker?
Bio Sequence
2 min read
Biological Glossary | What is Linker?
8 November 2023
In biology, linkers refer to short amino acid sequences found in nature that separate multiple domains in a single protein.
Read →
Biological Glossary | What is Intron?
Bio Sequence
2 min read
Biological Glossary | What is Intron?
8 November 2023
An intron, derived from the term "intragenic region", is a nucleotide sequence within a gene that does not directly code for proteins and does not remain in the final mature mRNA molecule following the gene's transcription.
Read →
Biological Glossary | What is Hairpin Sequence?
Bio Sequence
2 min read
Biological Glossary | What is Hairpin Sequence?
7 November 2023
In a hairpin sequence, the strand loops out and then come back to pair with itself, forming a double helix (the stem) ending in an unpaired loop.
Read →
Biological Glossary | What is Fusion Protein?
Bio Sequence
2 min read
Biological Glossary | What is Fusion Protein?
7 November 2023
A fusion protein is a protein composed of at least two domains that are encoded by separate genes fused together so that they are transcribed and translated as a single unit, producing a single polypeptide.
Read →
The Evolving Competitive Landscape Behind Vyjuvek, the World’s First-ever Topical Gene Therapy
Bio Sequence
3 min read
The Evolving Competitive Landscape Behind Vyjuvek, the World’s First-ever Topical Gene Therapy
7 November 2023
According to the Patsnap Bio Sequence Database, the top 10 applicants for the Vyjuvek patent are Krystal Biotech with 32 applications, Holostem Terapie Avanzate Srl with 6 applications, and FONDATION A DE ROTHSCHILD with 2 applications.
Read →
The Competitive Landscape Behind the FDA-approved New Treatment for Biliary Tract Cancer, Keytruda
Bio Sequence
3 min read
The Competitive Landscape Behind the FDA-approved New Treatment for Biliary Tract Cancer, Keytruda
6 November 2023
According to the Patsnap Bio Sequence Database, the top 10 applicants for the Keytruda patent are Novartis AG with 438 applications, Merck Sharp & Dohme Corp. with 350 applications, and Merck Sharp & Dohme LLC with 299 applications.
Read →
Biological Glossary | What is Exon?
Bio Sequence
2 min read
Biological Glossary | What is Exon?
3 November 2023
Exons are coding sections of an RNA transcript, or the DNA encoding it, that are translated into protein.
Read →
Biological Glossary | What is Enhancer?
Bio Sequence
2 min read
Biological Glossary | What is Enhancer?
3 November 2023
Enhancers are one type of DNA sequence that has important functions in biology.
Read →
The Evolution of the Competitive Landscape Behind Regeneron's Pleasing Sales of High-dose Treatment for Macular Degeneration, Eylea
Bio Sequence
3 min read
The Evolution of the Competitive Landscape Behind Regeneron's Pleasing Sales of High-dose Treatment for Macular Degeneration, Eylea
3 November 2023
According to the Patsnap Bio Sequence Database, the top 10 applicants for the Aflibercept patent are Novartis with 80 applications, Regeneron with 60 applications, and Sanofi with 50 applications.
Read →
Biological Glossary | What is Cyclopeptide?
Bio Sequence
2 min read
Biological Glossary | What is Cyclopeptide?
31 October 2023
A cyclopeptide is a type of peptide in which the amino acid sequence forms a cyclic rather than a linear structure.
Read →
Biological Glossary | What is Conserved Sequence?
Bio Sequence
2 min read
Biological Glossary | What is Conserved Sequence?
31 October 2023
In biology, conserved sequences refer to molecular sequences with high similarity or identity.
Read →
Toripalimab: FDA Greenlights First made-in-China PD-1 and Its Evolving Competitive Landscape
Bio Sequence
3 min read
Toripalimab: FDA Greenlights First made-in-China PD-1 and Its Evolving Competitive Landscape
31 October 2023
According to the Patsnap Bio Sequence Database, the top 10 applicants for the toripalimab patent are as follows: Shanghai Junshi Biosciences with 52 applications, Cugene with 30 applications, and Guangzhou Zhiyi Biotech with 16 applications. For more applicants, please refer to the image below.
Read →